Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. Mar15CAR T-Cell Therapy: What's New
    Register
  2. Mar23Understanding the Role of Immunotherapy in Treating Cancer
    Part I of New Trends in ImmunotherapyRegister

Past workshops

For All Cancers

    1. Clinical Trials: How They Transform the Treatment of Cancer
    2. What’s New in Precision Medicine
    3. What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors
      Part I of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    4. How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer
    5. Understanding Diagnostic Technologies and Biomarkers

For Acute Lymphoblastic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer

For Acute Myeloid Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Bladder Cancer

    1. Bladder Cancer: Treatment Updates
      Part I of Life with Bladder Cancer

For Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. Metastatic Breast Cancer: Treatment Updates

For Chronic Lymphocytic Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Chronic Myelogenous Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Colorectal Cancer

    1. Colorectal Cancer Treatment: Progress & Advances

For Cutaneous T-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Diffuse Large B-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Follicular Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Leukemia

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Lung Cancer

For Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Mantle Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Marginal Zone Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options

For Metastatic Breast Cancer

    1. Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the San Antonio Breast Cancer Symposium (SABCS)
      Part II of Living with Breast Cancer, with Updates from the San Antonio Breast Cancer Symposium (SABCS)
    2. Metastatic Breast Cancer: Treatment Updates

For Multiple Myeloma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Myelodysplastic Syndromes

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Myelofibrosis

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Myeloproliferative Neoplasms

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Non-Hodgkin Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Peripheral T-Cell Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Polycythemia Vera

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Small Lymphocytic Lymphoma

    1. What’s New in Diagnostic Technologies for People Living with Blood Cancers
      Part II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
    2. Update on CAR T-Cell Therapies

For Triple Negative Breast Cancer

    1. Metastatic Breast Cancer: Treatment Updates
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.